Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoid replacement therapy and fibrinolysis in hypopituitarism
2004-002056-34Phase 4Completed
- Sponsor
- Bradford Teaching Hospitals NHS Foundation Trust
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of hydrocortisone in hypopituitarism, sponsored by Bradford Teaching Hospitals NHS Foundation Trust. Primary endpoint: Change in fibrinolytic parameters. Started Feb 2005; status: completed.
02
Drugs
hydrocortisone
03
Conditions
hypopituitarism
Beyond the preview
Go deeper on 2004-002056-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002056-34.